Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.25M | -19.54M | -38.35%-21.49M | -15.53M | ||||||
| Net income from continuing operations | ---22.21M | ---21.06M | -35.77%-21.93M | ---- | ---- | ---- | ---- | ---16.15M | ---- | ---- |
| Operating gains losses | --83K | --309K | 117.76%219K | ---- | ---- | ---- | ---- | ---1.23M | ---- | ---- |
| Depreciation and amortization | --417K | --418K | 16.81%403K | ---- | ---- | ---- | ---- | --345K | ---- | ---- |
| Remuneration paid in stock | --1.51M | --1.54M | 13.53%1.7M | ---- | ---- | ---- | ---- | --1.5M | ---- | ---- |
| Other non cashItems | ---13K | --10K | -157.14%-18K | ---- | ---- | ---- | ---- | ---7K | ---- | ---- |
| Change In working capital | --1.97M | ---751K | -11,756.25%-1.87M | ---- | ---- | ---- | ---- | --16K | ---- | ---- |
| -Change in receivables | --1.39M | ---683K | -0.62%-324K | ---- | ---- | ---- | ---- | ---322K | ---- | ---- |
| -Change in inventory | --12K | ---85K | 435.71%150K | ---- | ---- | ---- | ---- | --28K | ---- | ---- |
| -Change in payables and accrued expense | --567K | --17K | -645.48%-1.69M | ---- | ---- | ---- | ---- | --310K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | ---18.25M | ---19.54M | -38.35%-21.49M | ---- | ---- | ---- | ---- | ---15.53M | ---- | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -36.42%-772K | 17.85%-537K | 254.81%1.11M | 14.24%-2.28M | 20.61%-364K | 20.59%-565.91K | -52.64%-653.7K | 27.52%-717K | -187.29%-2.66M | -354.34%-458.52K |
| Net PPE purchase and sale | ---772K | 20.82%-537K | 65.41%-248K | 5.35%-2.27M | ---363K | ---- | ---678.17K | ---717K | -54.76%-2.39M | ---- |
| Net intangibles purchas and sale | --0 | --0 | --1.36M | -84.44%-14K | ---1K | ---13.84K | ---- | --0 | 91.41%-7.59K | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---256.89K | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | 22.53%-552.07K | -281.30%-653.7K | ---- | ---- | 13.48%-458.52K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -36.42%-772K | 17.85%-537K | 254.81%1.11M | 14.24%-2.28M | 20.61%-364K | 20.59%-565.91K | -52.64%-653.7K | 27.52%-717K | -187.29%-2.66M | -354.34%-458.52K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -101.52%-294K | -102.97%-442K | -170.25%-1.09M | 127.02%112.83M | 194.41%78.4M | 7,339.96%19.36M | 2,374.94%14.88M | -92.90%1.55M | 132.94%49.7M | 21,846.96%26.63M |
| Net issuance payments of debt | -70.67%-294K | -63.21%-312K | -246.84%-548K | -67.03%-2.24M | -899.02%-1.72M | 15.17%-172.26K | 50.29%-191.16K | ---158K | 4.52%-1.34M | ---172.37K |
| Net common stock issuance | --0 | -99.99%1K | -65.95%618K | 115.20%115.73M | 179.69%78.67M | 3,276.60%20.77M | 1,268.35%16.22M | -92.26%1.82M | 126.54%53.78M | 217,498.70%28.13M |
| Net other financing activities | --0 | 88.66%-131K | -1,016.35%-1.16M | 76.02%-656K | 209.99%1.46M | -711.10%-1.23M | -478.11%-1.16M | 93.41%-104K | -173.97%-2.74M | -877.82%-1.32M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -101.52%-294K | -102.97%-442K | -170.25%-1.09M | 127.02%112.83M | 194.41%78.4M | 7,339.96%19.36M | 2,374.94%14.88M | -92.90%1.55M | 132.94%49.7M | 21,846.96%26.63M |
| Net cash flow | ||||||||||
| Beginning cash position | 279.07%28.44M | 591.75%48.96M | 234.10%70.46M | 124.22%21.09M | 116.04%10.62M | -42.36%7.5M | -66.34%7.08M | 127.48%21.09M | -35.09%9.41M | -68.31%4.91M |
| Current changes in cash | -650.00%-19.32M | -7,372.80%-20.51M | -46.09%-21.47M | 310.89%49.31M | 255.93%59.8M | 141.32%3.51M | 103.62%282.06K | -221.91%-14.7M | 296.20%12M | 388.51%16.8M |
| Effect of exchange rate changes | 99.76%-1K | 97.30%-3K | -106.31%-33K | 114.21%57K | 105.77%41K | -449.61%-417.86K | -164.72%-110.95K | 8,553.44%523K | -139.38%-401.1K | -139.57%-710.6K |
| End cash Position | -13.94%9.12M | 292.35%28.44M | 607.85%48.96M | 235.42%70.46M | 235.43%70.46M | 128.59%10.6M | -45.94%7.25M | -67.58%6.92M | 123.66%21.01M | 123.66%21.01M |
| Free cash from | -24.35%-19.02M | -43.99%-20.07M | -33.77%-21.74M | -69.53%-63.52M | -98.51%-18.6M | -90.09%-15.3M | -69.60%-13.94M | -84.34%-16.25M | -33.02%-37.47M | -59.33%-9.37M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |